Home » Market News » DirectorsTalk Highlights » Autoimmune disorders on the rise among young women
Immupharma Plc

Autoimmune disorders on the rise among young women

It occurs when immune system attacks the body’s own organs, tissues, and cells

With a growing number of women of reproductive age being diagnosed with autoimmune diseases such as lupus and APS, experts believe the disorder is adversely affecting fertility in such females and in some cases may even lead to miscarriage, foetal death and premature birth.

According to doctors, there is a rise in the cases of autoimmune diseases among women, including those of reproductive age.


Few AIM-listed drug development companies have late-stage clinical assets in the pipeline, ImmuPharma plc (LON:IMM) is an exception. The Company’s lead compound, Lupuzor™, a potential treatment for Lupus, has completed Phase 3 trial of dosing patients across the US, Europe and Mauritius with top line results announced.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.